Concepedia

Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial

Geert D’Haens, Carlos Taxonera, Antonio López–Sanromán, Pilar Nos, Silvio Danese, Alessandro Armuzzi, Xavier Roblin, Laurent Peyrin-Biroulet, Rachel West, Wout G.N. Mares,

˜The œLancet. Gastroenterology & hepatology · 2024 · 37 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

Predictability of the postoperative course of Crohn's disease

P. Rutgeerts, Karel Geboes, G. Vantrappen et al. · Gastroenterology · 1990 · 1.8K citations

, , +9

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

Geert D’Haens, Karel Geboes, Filip Baert et al. · Gastroenterology · 1998 · 867 citations · Full text

, , +14

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.

Paul Rutgeerts, Karen Geboes, Gaston Vantrappen et al. · Gut · 1984 · 788 citations · Full text

, , +17